cover
Contact Name
Rachmat Hidayat
Contact Email
dr.rachmat.hidayat@gmail.com
Phone
+6281949581088
Journal Mail Official
editor.bioscmed@gmail.com
Editorial Address
Jl. Sirna Raga no 99, 8 Ilir, Ilir Timur 3, Palembang
Location
Kota palembang,
Sumatera selatan
INDONESIA
Bioscientia Medicina : Journal of Biomedicine and Translational Research
Published by HM Publisher
ISSN : -     EISSN : 25980580     DOI : https://doi.org/10.37275/bsm
Core Subject : Health, Science,
This journal welcomes the submission of articles that offering a sensible transfer of basic research to applied clinical medicine. BioScientia Medicina covers the latest developments in various fields of biomedicine with special attention to : 1.Rhemumatology 2.Molecular aspect of Indonesia Traditional Herb 3.Cardiology and Cardiovascular diseases 4.Genetics 5.Immunology 6.Environmental health 7.Toxicology 8. Neurology 9. Pharmacology 10. Oncology 11. Other multidisciplinary studies related medicine. The views of experts on current advances in nanotechnology and molecular/cell biology will be also considered for publication as long as they have a direct clinical impact on human health.
Articles 1,526 Documents
Segmental Open Mandibular Fracture with Type 2 Diabetes Mellitus Managed by Intraoral Open Reduction, Internal Fixation and 101 Days of Arch Bar Retention: A Case Report with a Structured Care-Gap Analysis Deasy Nurwianti; Al Hafiz; Tuti Handayani
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 10 No. 10 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v10i10.1665

Abstract

Background: Mandibular fracture is the maxillofacial injury most often treated operatively, and road traffic collision is its dominant cause. Published series report fixation technique and union; far fewer report the perioperative variables that govern outcome when a metabolic comorbidity is present. Objective: To present the staged intraoral repair of a segmental open mandibular fracture in an adult with type 2 diabetes mellitus and, through a structured audit of the record, to identify the measurable perioperative determinants of outcome that were not documented during care. Case presentation: A 51-year-old man was struck by a car while riding a motorcycle and sustained a multiple open mandibular fracture of the symphysis, right parasymphysis and a segmental right body, with an anterior open bite, an interincisal opening of 24 mm, right mandibular crepitus and an avulsed right mandibular canine. He had treated hypertension and type 2 diabetes mellitus. Computed tomography with three-dimensional reconstruction defined the pattern and excluded condylar and intracranial injury. On the eighth day after injury, intraoral open reduction with four plates was combined with Erich arch bar maxillomandibular fixation. Rigid intermaxillary fixation was released at 21 days and the mandibular arch bar retained for 101 days. At day 116 mouth opening was unrestricted and mastication pain-free, with no infection, dehiscence, malunion or plate exposure. Structured review of the record showed that four determinants of outcome were never documented: any glycaemic measurement, inferior alveolar nerve sensation, the disposition of the avulsed canine and the retained dental roots, and a closing interincisal measurement. Conclusion: A staged intraoral repair restored occlusion and function in a diabetic adult with a segmental open mandibular fracture. The favourable result was achieved despite four recording gaps, each fixable at no cost, that would have converted a good outcome into a demonstrated one.
Excess Adiposity Predicts In-Hospital Mortality but Not SCORTEN in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: A Three-Year Retrospective Cohort at Dr. Moewardi General Hospital, Surakarta Nugrohoaji Dharmawan; Aulia Yasmin
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 10 No. 10 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v10i10.1666

Abstract

Background: Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare drug-induced reactions in which in-hospital death occurs in 12–49% of cases, yet the reference prognostic instrument, SCORTEN, contains no anthropometric variable. Whether body mass index (BMI) carries independent prognostic information is unknown. Objective: To determine whether body mass index carries independent prognostic information — for in-hospital mortality and for the SCORTEN severity score — in adults admitted with Stevens–Johnson syndrome and toxic epidermal necrolysis. Methods: This retrospective observational analytic study used total sampling of the ICD-10 L51.1/L51.2 admission register at Dr. Moewardi General Hospital, Surakarta, from January 2022 to December 2024. Forty-three adults were classified by Asia-Pacific BMI thresholds and analysed against SCORTEN, diagnostic class and in-hospital mortality using exact, Firth-penalised and interval-valued methods, with STROBE reporting. Results: Eight patients died (18.6%; 95% CI 9.7–32.6). BMI was not associated with SCORTEN (Spearman ρ = 0.163; 95% CI −0.14 to 0.44; p = 0.296), and all 3,280 exhaustively enumerated reconstructions of the incompletely reported score distribution reproduced a non-significant coefficient (ρ 0.061–0.287); the minimum detectable |ρ| was 0.42, so this null is uninformative rather than negative (BF01 = 3.10). Mortality rose across the ordered BMI strata from 0% to 36.4% (Cochran–Armitage z = 2.053; p = 0.040, exact permutation p = 0.056), and at the Asia-Pacific overweight threshold reached 35.3% versus 7.7% (odds ratio 6.55; 95% CI 1.14–37.75; Fisher exact p = 0.042; Firth-penalised odds ratio 5.54, 95% CI 1.20–34.09; number needed to harm 3.6; E-value 8.65; fragility index 1). Conclusion: Excess adiposity is associated with in-hospital death in Indonesian patients with epidermal necrolysis through a channel SCORTEN does not capture. The estimate is imprecise and requires prospective multicentre confirmation.
Visual Recovery to 6/6 After Plasma Exchange Begun 29 Days Into a Corticosteroid-Refractory Aquaporin-4-IgG-Positive Optic Neuritis Attack: A Case Report Anak Agung Ayu Putri Oktiadewi; Anak Agung Mas Putrawati Triningrat; Gede Kambayana; Ni Kadek Mulyantari; I Gusti Ayu Made Juliari
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 10 No. 10 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v10i10.1667

Abstract

Background: Optic neuritis in aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica spectrum disorder (NMOSD) is severe and frequently corticosteroid-refractory. Plasma exchange is recommended within days of onset, and the evidence that later treatment still helps is thin. Whether an attack first treated a month after onset can still recover fully is unresolved. Objective: To describe the visual and structural recovery that followed therapeutic plasma exchange begun 29 days after onset — far outside the recommended window — in a corticosteroid-refractory aquaporin-4-IgG-positive optic neuritis attack, and to audit the record against the quantified determinants of outcome. Case presentation: A 34-year-old woman with systemic lupus erythematosus, antiphospholipid syndrome and AQP4-IgG seropositivity documented one month earlier presented 24 days after the onset of painful visual loss in the right eye. Best-corrected visual acuity was 3/60 and the Ishihara score 0 of 25. No relative afferent pupillary defect was demonstrable in the affected eye, because the fellow eye, atrophic since an attack 11 years earlier, showed the defect instead. A full Optic Neuritis Treatment Trial course of intravenous methylprednisolone, from day 24 to day 27, produced no measurable change. Plasma exchange was started on day 29; acuity reached 6/60 on day 33 and 6/6 on day 35, and the Ishihara score rose to 5 of 25 by day 40 without any procedure-related adverse event. At day 53 the peripapillary retinal nerve fibre layer measured 91 micrometres in the treated eye against 41 in the fellow eye. Conclusion: Complete recovery of high-contrast acuity followed plasma exchange begun 29 days after onset, far outside the recommended window, while colour vision recovered only partially. A chronically damaged fellow eye can abolish the relative afferent pupillary defect in an acutely inflamed eye, and the attack occurred on azathioprine in a patient already known to be seropositive.
Acute Changes in Cartilage Oligomeric Matrix Protein and CTX-II Following Endurance Running in Adults: A Systematic Review and Meta-analysis Made Anggi Paramitha; Bagus Gede Krisna Astayogi; Komang Adinda Permitasari Bramastya
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 10 No. 10 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v10i10.1668

Abstract

Background: Acute running-related changes in cartilage oligomeric matrix protein (COMP) and the C-terminal cross-linked telopeptide of type II collagen (CTX-II) should not be interpreted automatically as structural cartilage injury. This review evaluated the magnitude and consistency of these biomarker responses after endurance running. Objective: To quantify the magnitude and consistency of the immediate post-run change in serum cartilage oligomeric matrix protein (COMP), and to summarize the corresponding CTX-II responses, in adults following endurance running. Methods: The protocol was registered in PROSPERO (CRD420261485170). PubMed/MEDLINE, CENTRAL, ClinicalTrials.gov, WHO ICTRP, OpenAlex, Crossref, and citation networks were searched for adult running studies reporting pre- and post-exercise COMP or CTX-II. The primary effect was the log ratio of immediate post-run to pre-run serum COMP. Random-effects models used restricted maximum likelihood with Hartung-Knapp inference. Results: The search identified 221 unique reports; seven reports met the criteria for qualitative synthesis, and four compatible healthy-adult COMP estimates involving 57 participants entered the meta-analysis. The pooled post/pre ratio was 1.132 (95% CI 0.794–1.613), with τ²=0.0365, I²=89.0%, and a 95% prediction interval of 0.560–2.286 at ρ=0.50. Three estimates increased and one decreased after running. CTX-II and recovery findings were too heterogeneous for pooling. Certainty was very low. Conclusion: Serum COMP may change acutely after endurance running, but the direction and magnitude are inconsistent. These short-term surrogate responses do not establish cartilage damage, protection, or long-term clinical harm.
Sequential Inflammatory and Pupillary-Block Ocular Hypertension in Streptococcus suis Endogenous Endophthalmitis: An Observational Analytic Case Study Dewa Ayu Ina Dianata; I Gusti Ayu Made Juliari; I Gusti Ayu Ratna Suryaningrum; Ni Made Ari Suryathi; Anak Agung Ayu Suryapraba Indradewi
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 10 No. 10 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v10i10.1669

Abstract

Background: Streptococcus suis, a zoonosis acquired from pigs and raw pork, is a rare cause of endogenous endophthalmitis, and no quantitative account of the pressure complications of such an eye has been published. Objective: To characterize, in a single culture-proven case of Streptococcus suis endogenous endophthalmitis, the two mechanisms and the course of the raised intraocular pressure, and to derive the clinical implications for management. Methods: a structured analysis of one culture-proven case managed at a tertiary hospital in Bali, Indonesia, over 48 days. Acuity was converted to logMAR on four published scales, all 19 pressure readings were analysed with a repeatability model, and corticosteroid causation was scored with the Naranjo instrument. Results: a 46-year-old man who had eaten raw pork a week earlier presented with meningitis, reduced hearing and a left eye with light perception, hypopyon and vitritis. Cerebrospinal fluid and vitreous both grew S. suis. Pressure rose in two distinct episodes: an inflammatory one peaking at 29.0 mmHg on day 7, and a pupillary block from posterior synechiae with iris bombé peaking at 30.0 mmHg on day 16, which fell 11.0 mmHg after iridotomy with simultaneous reintroduction of timolol. Corticosteroid causation scored 3, a value largely fixed by the temporal sequence alone. Acuity improved by 0.70 logMAR overall, but the division of that gain across the vitrectomy reversed with the conversion scale: 0.40 before and 0.30 after by clinical convention against 0.10 and 0.60 with measured hand-movement values. The eye remained blind. Conclusion: raised pressure in such eyes is not one entity, the pupil must be examined before pressure-lowering therapy is escalated, and a logMAR change at this level of vision is uninterpretable unless its scale is stated.
Vision-Related Quality of Life in Moderate-to-High Myopia Corrected with Rigid Gas Permeable Contact Lenses: A West Sumatran Cross-Sectional Study Risa Rilanda; Rinda Wati
Bioscientia Medicina : Journal of Biomedicine and Translational Research Vol. 10 No. 10 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research
Publisher : HM Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37275/bsm.v10i10.1670

Abstract

Background: Rigid gas permeable (RGP) contact lenses correct highly ametropic eyes better than spectacles can, but whether that optical advantage reaches the patient, and what predicts it, is unstudied in Indonesia. Objective: To characterize vision-related quality of life, and to test whether clinical variables predict it, in adults with moderate-to-high myopia corrected with rigid gas permeable contact lenses in West Sumatra, Indonesia. Methods: In an analytical cross-sectional study, 26 adults with a spherical equivalent of at least −3.00 dioptres who had worn RGP lenses for at least one month were recruited at the Refraction, Contact Lens and Low Vision Subdivision of Dr. M. Djamil Central General Hospital, Padang, West Sumatra, between July and August 2025. Acuity was recorded in logMAR before fitting and with the lens, and quality of life with the Indonesian National Eye Institute Visual Function Questionnaire-25; predictors were related to the composite and 12 subscales by Spearman and Mann–Whitney tests, with Benjamini–Hochberg control across all 104 tests. Results: The median composite score was 93.21 (62.95–97.16) and 20 of 26 (76.9%, 95% CI 56.4–91.0) scored at or above the visually-normal normative mean of 85.48. Every participant gained at least 0.304 logMAR, 3.0 times the 0.10 logMAR minimum clinically important difference, the median gain being identified to 1.374–1.470 logMAR. Three tests reached p < 0.05 against 4.9 expected under the global null and none survived correction (smallest q = 0.989); with a minimum detectable |ρ| of 0.557, six subscales at their ceiling and a corrected-acuity range below one such difference, the predictor analysis is uninformative rather than negative. Conclusion: RGP correction restored near-normal function and patient-reported vision; a future Indonesian study needs about 89 participants.

Filter by Year

2017 2026


Filter By Issues
All Issue Vol. 10 No. 10 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 9 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 8 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 7 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 6 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 5 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 4 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 3 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 2 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 10 No. 1 (2026): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 12 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 11 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 10 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 9 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 8 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 7 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 6 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 5 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 4 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 3 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 2 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 9 No. 1 (2025): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 12 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 11 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 10 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 9 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 8 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 7 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 6 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 5 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 4 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 3 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 2 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 8 No. 1 (2024): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 12 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 11 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 10 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 18 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 17 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 9 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 8 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 7 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 6 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 5 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 4 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 3 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 2 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 7 No. 1 (2023): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 16 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 15 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 14 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 13 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 12 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 11 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 10 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 9 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 8 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 7 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 6 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 5 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 4 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 3 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 2 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 6 No. 1 (2022): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 12 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 11 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 10 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 9 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 8 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 7 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 6 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 5 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 4 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 3 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 2 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 5 No. 1 (2021): Bioscientia Medicina: Journal of Biomedicine & Translational Research Vol. 4 No. 4 (2020): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 4 No. 3 (2020): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 4 No. 2 (2020): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 4 No. 1 (2020): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 3 No. 4 (2019): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 3 No. 3 (2019): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 3 No. 2 (2019): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 3 No. 1 (2019): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 2 No. 4 (2018): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 2 No. 3 (2018): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 2 No. 2 (2018): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 2 No. 1 (2018): Bioscientia Medicina: Journal of Biomedicine and Translational Research Vol. 1 No. 1 (2017): Bioscientia Medicina: Journal of Biomedicine and Translational Research More Issue